Camylofin Dihydrochloride is a synthetic antispasmodic agent that relaxes smooth muscle of the uterus and gastrointestinal tract, used to relieve pain in dysmenorrhoea and GI colic. Simson Pharma's Camylofin Dihydrochloride reference standard supports compendial QC for this regional antispasmodic.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Camylofin dihydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.